To that end, we dosed relapsed AML mice with recombinant mouse E-selectin 20 minutes prior to blood exchange with a healthy recipient, in order to occupy glycoproteins on the leukemia cell surface (Fig. 4a). The gene discussed is SELE; the disease is acute myeloid leukemia.